Claire F. Verschraegen
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
512
Citations
11,308
Est. group size
~22
Recurring co-author estimate
Active years
41
Publishing since 1986
Claire F. Verschraegen's work centers on clinical trials for advanced and metastatic cancers, including prostate, lung, skin, and breast cancers, testing new drugs and treatment combinations such as immunotherapies, oncolytic viruses, and engineered bacterial agents. Much of the research involves phase 1 and 2 clinical studies evaluating safety, efficacy, and novel therapeutic strategies, often in collaboration with large multi-institutional teams. This work is applied and clinically oriented, aimed at improving treatment options for patients with hard-to-treat cancers.
Publication output grew substantially over the last decade, rising from single digits around 2017-2018 to a peak of 72 in 2023, followed by a slight decline but continued high output in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Rethinking combination strategies in metastatic castration-resistant prostate cancer (mCRPC)—lessons from KEYNOTE-641
Translational Andrology and Urology · 2026
- Anti-tumor activity of FF-10850 (liposomal topotecan) in patients with advanced Merkel cell carcinoma.
Journal of Clinical Oncology · 2026
- NCI Awardee Skills Development Consortium (NASDC): a Successful Novel Educational Effort to Maintain Early Academic Competitiveness: PART 1—Overview of the NASDC Coordinating Center
Journal of Cancer Education · 2025
- Safety and efficacy results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ transplant recipients with advanced cutaneous malignancies (ARTACUS)
EJC Skin Cancer · 2025
- End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report
Anticancer Research · 2025
- Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Anticancer Research · 2025
- Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer
Cancer Treatment and Research Communications · 2025
- Supplementary Table S1 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
2025
- Supplementary Figure S2 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
2025
- Supplementary Figure S4 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
2025
- Supplementary Figure S3 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
2025
- Supplementary Figure S6 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
2025
- Supplementary Figure S1 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
2025
- Supplementary Figure S5 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
2025
- Supplementary Table S2 from Phase I Study of SYNB1891, an Engineered <i>E. coli</i> Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
2025
- Journal of Clinical Oncology×37
- Annals of Oncology×9
- Regular and Young Investigator Award Abstracts×6
- Cancer Research×6
- BMC Cancer×4
- Seung‐Oe Lim
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Wonkyung Oh
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Alyssa Min Jung Kim
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Samantha Sharma
Biochemistry, Genetics and Molecular Biology · Indiana University
- Titto Augustine
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile